Study on efficacy of Habbe Asgandh in Waja ul Rukba (knee arthralgia)

Clinical study to evalauate the efficacy of Habbe Asgandh (Unani formulation) in the management of Waja ul Rukba (knee arthralgia)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/08/027058

Enrollment

Registered

2020-08-10

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M179- Osteoarthritis of knee, unspecified

Interventions

Intervention1: Habbe Asgandh: Ajwayin desi (Trachyspermum ammi)20gm Asgandh (Withania somnifera) 40gm Bidhara (Argyreia nervosa)40gm Peepla mool (Piper longum) 20gm Pipal kalan (Piper longum)20g Zanja

Eligibility

Inclusion criteria

Inclusion criteria: Known patients of Waja-ul-Rukba will be taken on the basis of clinical presentation general physical examination Patients with 25 to 60 years of either gender Patients attending OPD of reputed college and hospital Patient willing to participate in the study

Exclusion criteria

Exclusion criteria: Patients suffering from systemic disease like ischaemic heart disease, uncontrolled diabetes and hypertension, chronic obstructive airway disease, cancer, anaemia, acute fever or infection, convulsions, haematological disorder etc Pregnancy and lactation

Design outcomes

Primary

Measure	Time frame
Change in VAS pain scaleTimepoint: Baseline, 7th, 14th, 21st and 28th day	—

Secondary

Measure	Time frame
Change in Quality of Life using KOOSTimepoint: Baseline and after treatment	—

Countries

India

Contacts

Public ContactShagufta Parveen

ZVM Unani Medical College

prof.ahfarooqui@yahoo.com9822234792

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026